India faces a unique tobacco control challenge due to a large economically weak tobacco using population. It is important for decision makers to consider the...
New Delhi: The Drugs Controller General of India (DCGI) has approved Hyderabad-based Biological E. Limited for conducting Phase III comparator safety and immunogenicity trial in...